SNX9 and glomerular disorder: We demonstrate that SNX9 is strongly expressed and co-localizes with podocin in both kidneys from adriamycin (ADR)-injected mice and kidney biopsy samples from human patients with glomerular diseases leading to glomerulosclerosis.